NEW YORK (GenomeWeb) – Qiagen said this week that it will be begin offering a quality control set and verification data with its GeneReader NGS System. The company will integrate Horizon Discovery Group's industry-standard reference control data set into the GeneReader NGS workflow. Further, Qiagen said its GeneRead QIAact Actionable Insights Tumor Panel has demonstrated accuracy, consistency, and reliability in testing compared with Horizon's control data.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.